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Abstract 
Systematic reviews have considerable potential to provide evidence-based data to aid 
clinical decision-making. However there is growing recognition that trials involving 
mechanical ventilation lack consistency in the definition and measurement of ventilation 
outcomes, creating difficulties in combining data for meta-analyses. To address the 
inconsistency in outcome definitions, international standards for trial registration and 
clinical trial protocols published recommendations, effectively setting the ‘gold standard’ for 
reporting trial outcomes. In this Critical Care Perspective, we review the problems resulting 
from inconsistent outcome definitions and inconsistent reporting of outcomes (outcome 
sets). We present data highlighting the variability of the most commonly reported 
ventilation outcome definitions. Ventilation outcomes reported in trials over the last six 
years typically fall into four domains: measures of ventilator dependence; adverse 
outcomes; mortality; and resource utilization. We highlight the need first, for agreement on 
outcome definitions and second, for a minimum core outcome set for trials involving 
mechanical ventilation. A minimum core outcome set would not restrict trialists from 
measuring additional outcomes, but would overcome problems of variability in outcome 
selection, measurement and reporting thereby enhancing comparisons across trials.  
 
Keywords: core outcome measures; critical care trials; systematic reviews 
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Background  
Many interventions applied in the critically ill influence the duration of mechanical 
ventilation.  Measures of ventilator dependence, such as duration of ventilation, are 
frequently used as primary and secondary outcomes. However, variations in outcome 
definitions lead to differences in estimates of treatment effects and in a systematic review 
this ‘artefactual difference’ may dilute the real effect (1).  As such, it is highly desirable that 
standardized outcome definitions are used in trials examining interventions likely to affect 
duration of mechanical ventilation. This will enable treatment effects to be compared in an 
unbiased, reliable and robust manner.  
 
Consistency in the measurement and reporting of trial outcomes is lacking. Williamson and 
colleagues noted that the most accessed and cited Cochrane reviews in 2009 all described 
inconsistencies in trial outcomes (2). Two recent systematic reviews of the effectiveness of 
protocolized weaning highlighted inconsistencies in measurement time points for 
ventilation outcomes (3, 4). Current international standards for trial registration (CONSORT, 
WHO registry) and the recent SPIRIT 2013 recommendations for writing clinical trial 
protocols stress that investigators should report the specific measurement variable and time 
frame for each outcome measure when registering trials (5-7). However, analysis of a cohort 
of records from the clinicaltrials.gov database indicated that 36% of trials registered a 
domain only and lacked definition of the specific measure, metric used or method of 
aggregation of results.  (8). Furthermore, outcomes included in trial protocols are not always 
reported in trial publications (9, 10).  
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In addition to the need for consistency in outcome definitions, Williamson and colleagues 
called for the development and use of core outcome sets (2), defined as an “agreed, 
standardized collection of outcomes measured and reported in all trials for a specific clinical 
area” (11). Agreement on a core outcome set should avoid problems associated with 
selective reporting of outcomes. The COMET (Core Outcome Measures in Effectiveness 
Trials) database has registered more than 260 references of planned work in developing 
core outcome sets and among them there are three studies exploring ventilation outcomes; 
long-term outcomes in acute respiratory failure; and rehabilitation following critical illness 
(12).  
 
Little is known about how ventilation outcomes are defined and measured.  To investigate 
this we sought to: first, identify trials involving mechanically ventilated adults and children 
that reported ventilation outcomes and describe how these outcomes were reported; and 
second, explore how trials specifically evaluating ventilation interventions reported 
ventilation outcomes and whether these might reveal a core outcome set. 
 
Review process 
We included trials published in the top ranked journals between January 2007 and 
December 2012 in general medicine (New England Journal of Medicine; Lancet; Journal of 
American Medical Association; Pediatrics) and critical care journals (American Journal of 
Respiratory and Critical Care Medicine; Critical Care Medicine; Intensive Care Medicine; 
Pediatric Critical Care Medicine).  We specifically chose top ranked journals because of the 
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likelihood of locating high quality trial reports. Rankings were based on the impact factors in 
the ISI Web of Knowledge, Journal Citation Reports 2011, Thomson Reuters. Our review only 
included randomized controlled trials involving adults or children receiving invasive 
mechanical ventilation and measuring outcomes pertaining to the duration of ventilation 
and its discontinuation.  Three authors (BB, LR, PMcG) divided the journals and 
independently searched, screened and extracted data.  Titles and abstracts of papers in the 
journals were reviewed: full texts including supplementary material, published protocols or 
protocol registrations of all potentially relevant trials were retrieved.  Details of the trials’ 
aims, primary and secondary outcome measures and their definitions were extracted onto 
pre-piloted data extraction forms (see online data supplement, appendix 1). These forms 
were reviewed by the three authors to confirm inclusion:  a fourth author (DMcA) acted as 
arbitrator.   
 
Results 
We included 66 reports of randomized trials (13-78) and associated documentation (59 trial 
registrations; 34 electronic supplementary materials; 13 published protocols) (Figure 1).  
Interventions addressed management of ventilation; sedation; physiotherapy; nutrition; 
renal/fluid management; medications and infection prevention. The 66 trials reported 30 
different primary outcomes. Primary outcomes reported by more than 1 trial and secondary 
outcomes reported by more than 10 trials are shown in Figure 2.  
 
Nine ventilation outcomes were reported across included trials reflecting measures of 
ventilator dependence or occurrence of events (typically adverse outcomes) (Table 1). 
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Duration of ventilation was the most commonly reported outcome yet only  12 trials (25%) 
provided a definition (20, 24, 30, 32, 35, 42-44, 61, 64, 71, 73) with substantial variation in 
time point measures. Twenty-five trials reported ventilator-free days as an outcome, 9 
(36%), (18, 19, 23, 51, 53, 62, 63, 72, 73) provided no definition and variable start and end 
points  were reported in the 16 (64%) providing a definition (24, 26, 31, 45, 50, 52, 54, 57, 
58, 65, 66, 68-70, 72, 76) there were variable start and end points (Table 2). Three trials 
reporting weaning duration as a secondary outcome (24, 62, 76) and only one provided a 
definition (24).  When reintubation was reported as a trial outcome (4 trials), follow-up was 
measured at 24-hours (73), 48-hours (49, 61) or 7-days (32). When reintubation was 
recorded as an adverse event (4 trials) (31, 40, 55, 71), the follow-up period within which 
this was measured was not provided.  
 Outcomes reported in trials specifically evaluating a ventilation intervention 
Twelve trials tested a ventilation intervention including sedation and ventilation weaning 
methods (20, 30, 31, 43, 44, 49, 68);  ventilator modes (27, 78); automated systems to 
facilitate  ventilator weaning (61, 64); and early non-invasive ventilation following invasive 
ventilation (32). Primary and secondary outcomes reported in these trials are presented in 
Figure 3. Outcome measures reflected four domains; measures of ventilator dependence 
(e.g. duration of ventilation, duration of weaning, separation potential); adverse outcomes 
(e.g. VAP, reintubation, self extubation); mortality and survival outcomes (e.g. survival, ICU 
mortality, hospital mortality); and resource utilization (e.g. ICU LOS, hospital LOS, clinical 
workload). 
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There was considerable variation in measuring primary outcomes. Ventilation trials reported 
either duration of mechanical ventilation or ventilator-free days, but not both. Start and 
endpoints are shown in Table 3. In secondary outcomes, mortality was reported for 
different follow up periods  that included: ICU (20, 49, 68, 78); hospital (20, 68, 78); 28-day 
(31, 64); 30-day (30); 90-day (31); and prior to ventilator separation potential and 
extubation (61). One trial did not define the follow up period (27) and one trial did not 
measure mortality (43).  Two trials measured survival, at 1-year (31) and at an undefined 
time point (32). 
 
Discussion 
We found substantial variation in the outcome sets used. Outcome definitions differed 
between trials, often measuring different time points and different follow up periods. 
Furthermore, a large number of trials lacked detail in their outcome definitions.  
 
It is important to highlight the effect related to the competing risk of death in using duration 
of ventilation as an outcome measure. Various statistical methods have tried to address this 
issue. Egleston and colleagues(79) point out that by using a basic approach of examining 
outcomes in survivors only it is possible that a harmful intervention will increase mortality in 
a vulnerable population. These remaining healthier survivors may have a reduced duration 
of ventilation giving the impression that the intervention has a beneficial effect. (79) 
Therefore it is important to consider the duration of ventilation as an outcome in the 
context of mortality. Measuring ventilator-free days (i.e. a composite outcome of mortality 
and duration of ventilation) is one method to address competing risks. (80) Our work has 
demonstrated that ventilator-free days are often poorly defined or not reported.  
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Cause specific hazard models that fail to take into account the competing event (death) 
results in the patient being censored from the analysis and may falsely make the 
intervention appear beneficial. (81) When a sub-distribution hazard model is employed 
patients are not censored despite the occurrence of the competing event. When events are 
mutually exclusive such as death or unassisted breathing and discharge home a parametric 
mixture survival model may be the most appropriate method to determine the true effect of 
an intervention. (82)  
 
The issue of competing risk is complex and does not just apply to mortality. An intervention 
intended to reduce the duration of mechanical ventilation may potentially lead to 
complications making it unclear whether the treatment causes the complication or results in 
more patients being alive to develop the complication. Statistical approaches such as cause 
specific hazard, cumulative incidence function and event-free survival are used to detect the 
true effect of an intervention. However, their ability to do so varies depending on whether 
the competing risk is affected in the same or opposite manner to the primary event being 
studied.(83) Regardless of these issues our finding of variability in mechanical ventilation 
outcome measures is important. 
 
The outcome ‘duration of mechanical ventilation’ was reported by 73% of all trials and was 
measured from either intubation or initiation of ventilation (which may or may not occur 
simultaneously). It is generally interpreted as intubation and initiation of mechanical 
ventilation occurring on ICU admission. However, initiation may occur in the Operating 
Room or Emergency Department and the start time point may be difficult to obtain or 
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inconsistently recorded. Furthermore, some trials reported randomization as the start point 
for ‘duration of mechanical ventilation’. Firstly, the criteria for randomization vary between 
trials. Secondly, enrollment in some trials, for example, investigating weaning methods, are 
dependent upon physician assessment and are prone to bias.  Finally, randomization may be 
delayed by the process of gaining consent, with consent windows up to 24 hours.  
 
We found the end time point for measuring duration of mechanical ventilation was reported 
as either ‘free from mechanical ventilation’ or extubation. Free from mechanical ventilation 
was defined as either freedom from invasive ventilation or both invasive and non-invasive 
ventilation. Timing of extubation may be influenced by organizational issues such as 
workload and staff availability (84, 85). These organizational issues may vary widely 
between institutions and across trials.   This wide variability in outcome definitions 
regarding start and end points of mechanical ventilation will not be problematic within a 
trial provided both arms are equally affected. However, it may lead to systemic variations 
when comparing trials, highlighting the need for agreed outcome definitions. 
 
In the 12 trials specifically evaluating a ventilation intervention, there was also time point 
variation in secondary outcomes. When reporting mortality, it is reasonable to choose a 
longer duration of follow up when delayed effects are expected, such as in ARDS or severe 
sepsis (86). However, consensus on duration of follow up is required if trials are to be 
compared. Length of stay (ICU and hospital) was frequently measured as a secondary 
outcome. Length of stay is an important healthcare resource utilization outcome. However, 
it has limitations, particular in comparing trials across countries with different healthcare 
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funding models and resource availability. Furthermore, contextual differences in end of life 
care practices may also affect duration of ventilation and length of stay. 
 
Although this paper is the first to provide data showing substantial variation in outcome 
definitions in ventilation trials, it is not the first to call for improvements in standardizing 
outcomes in critical care trials. A workshop convened by the National Heart, Lung and Blood 
Institute (87) recommended standardization in describing and collecting endpoints to 
facilitate meta-analyses of acute lung injury trials; and a Society of Critical Care Medicine 
stakeholder conference (88) highlighted the necessity of gaining consensus on a standard 
set of outcome measures for long term outcomes following ICU discharge.  
 
Our analysis indicates that outcomes reported in trials of ventilation interventions typically 
measure outcomes in a number of domains: measures of ventilator dependence; adverse 
outcomes; mortality and survival outcomes; and resource utilization.  For ICU patients, 
being free from ventilation and survival are clearly important outcomes, but length of stay 
may not be. Longer term outcomes such as cognitive and physical function and quality of life 
are often under reported. (87, 88) However, the effects of critical illness impacts on patients 
long after hospital discharge and these longer term outcomes are increasingly being 
recognized as being important by investigators. (89-91) The optimal duration of long term 
follow-up remains to be determined.  
 
The common domains that are addressed give rise to the possibility of obtaining agreement 
on outcome definitions and a core outcome set. A core outcome set would not restrict 
trialists from measuring additional outcomes, but would overcome problems of variability in 
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outcome selection, measurement and reporting thereby enhancing valid comparisons 
across trials. To address this, we are undertaking a study that will use the Delphi technique 
to achieve international consensus on core outcome definitions and a core outcome set for 
use in trials involving mechanical ventilation (http://www.comet-
initiative.org/studies/details/292?result=true). We will liaise closely with the International 
Forum for Acute Care Trialists (InFACT) and the Delphi panel will draw upon relevant 
stakeholders including patient groups, professional societies, clinical trial groups, and 
industry.  
 
Limitations 
Our search for trials was restricted to a short, but recent, time period and a small number of 
journals. It does not provide a full comprehensive overview of ventilation outcomes in trials 
across a longer time period and a wider range of journals; however, we are confident that 
we have presented sufficient data to demonstrate significant variability in outcome 
reporting in recent trials accepted for publication in high impact journals.  
 
 
Conclusion 
We show substantial variation in the choice of outcome measures and their definition in 
randomized trials evaluating interventions likely to influence the duration of ventilation. We 
anticipate the recent SPIRIT 2013 statement (7) outlining guidance for reporting clinical trial 
protocols will help investigators provide clear definitions enabling more appropriate 
comparisons. Expert consensus on, and implementation of, standardized outcome 
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definitions and core outcome sets is fundamental to reducing bias when comparing effects 
across trials. 
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Table 1  Summary of ventilation outcomes 
 
Outcome No of 
trials 
Reported as 
primary  
Reported as 
adverse event 
Definition 
provided 
N (%) 
 
Measures of ventilation 
dependence 
    
Duration of ventilation 48 9 - 12 (25%) 
Ventilator-free days 25 4 - 16 (64%) 
Weaning time 3 - - 1 (33%) 
Time to separation 
potential 
1 1 - 1 (100%) 
Occurrence of events     
Reintubation 8 2 4 4 (50%) 
Extubation failure 4 1 1 2 (50%) 
Use of post extubation 
NIV 
4 - 3 1 (25%) 
Weaning failure 1 1 - 1 (100%) 
Successful extubation 1 - - 0 
 
 
Key: NIV, non-invasive ventilation 
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Table 2  Start and end point variability for ventilation outcomes in 66 trials 
 
Start point Endpoint 
 
Duration of mechanical ventilation 
 
Commencement of IMV(20, 
30, 71) 
 
1st extubation(24, 30, 44, 61, 64) 
Intubation(43) Successful extubation(35, 61, 64) 
Randomization(24, 35, 42, 44, 
61, 64, 73) 
Successful extubation (UAB for 24(73), 48(43, 44) or 
72-hours(24)) 
  1st  SBT(64) 
 Successful SBT(61, 64) 
 Successful extubation (24-hours) or successful SBT 
(UAB for 48-hours)(42) 
 Ventilator free(71) 
 Free from IMV or NIV (for 48-hours)(35) 
Extubation from IMV and NIV stop or reintubation 
for NIV group(32) 
 Ventilation time within28-days(64) 
 Successful weaning(20, 61) 
VFD 
 
Day 1(50, 54) Day 28(24, 31, 45, 50, 52, 58, 65, 66, 68-70, 76) 
Intubation(50) Day 60(24) 
Randomization (24, 30, 40, 46, 
49, 51, 52, 81) 
Day 90(57) 
Not specifically stated(26, 65, 
69, 70, 76) 
Day 28 and 90(54) 
 Not specifically stated(72) 
  
 
Key: IMV, invasive mechanical ventilation; NIV, noninvasive mechanical ventilation; SBT, 
spontaneous breathing trial; UAB, unassisted breathing. Some trials measured more than 
one endpoint. 
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Table 3  Start and end point variability for ventilation outcomes in 12 ventilation 
trials 
 
Start point Endpoint 
 
Duration of mechanical ventilation 
 
Commencement of IMV(20, 
30) 
 
1st extubation(30, 61, 64) 
Intubation(43, 61) Successful extubation(61) 
Randomization(39, 76, 77) Extubation or a trache mask for 48-hours(43, 44) 
  Extubation from IMV and NIV stop or reintubation 
for NIV group(32) 
 1st SBT(32) 
 Successful SBT(32) 
 Successful weaning(20) 
VFD 
 
Intubation(68) Day 28(31, 68) 
Randomization(31, 68)  
 
Key: IMV, invasive mechanical ventilation; NIV, noninvasive mechanical ventilation; SBT, 
spontaneous breathing trial. Some trials measured more than one start and endpoint.   
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